Craft
  • Home
  •  / Protagonist Therapeutics
Protagonist Therapeutics

Protagonist Therapeutics

Revenue

$27.4 M

FY, 2021

Market Capitalization

$396.6 M

2022-11-14

Protagonist Therapeutics Summary

Company summary

Overview
Protagonist Therapeutics operates as a clinical-stage biopharmaceutical company. It offers drug discovery and development services. The company develops peptide technology platforms for the de novo discovery of drugs.
Type
Public
Status
Active
Founded
2006
HQ
Newark, CA, US | view all locations
Website
http://protagonist-inc.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Dinesh V. Patel

    Dinesh V. Patel, President, Chief Executive Officer and Director

  • David Y. Liu

    David Y. Liu, Chief Scientific Officer

  • Suneel Gupta

    Suneel Gupta, Chief Development Officer

  • Matthew Gosling

    Matthew Gosling, Executive Vice President, General Counsel

LocationsView all

2 locations detected

  • Newark, CA HQ

    United States

    7707 Gateway Blvd suite 140

  • Saint Lucia, QLD

    Australia

    306 Carmody Rd

Protagonist Therapeutics Financials

Summary financials

Cash (Q3, 2022)
$152.8M
Enterprise value
$248.0M

Footer menu